HSD17B7 is required for the function of sensory hair cells by regulating cholesterol synthesis

This study identifies HSD17B7 as an essential gene for sensory hair cell function and hearing, demonstrating that its deficiency disrupts cholesterol biosynthesis and subcellular localization, leading to profound sensorineural hearing loss.

The Gist

The Big Picture: The "Oil" of Your Ears

Imagine your ear's hearing system as a high-tech orchestra. The musicians are tiny cells called hair cells. These cells are so small and delicate that they can't just sit there; they need to be constantly tuned and lubricated to work.

The "lubricant" they need is cholesterol. You might know cholesterol as something bad for your heart, but in your ear, it's essential. It acts like the oil in a car engine or the grease on a door hinge. Without enough of it, the door sticks, and the engine sputters.

This paper discovers a specific "mechanic" in your body called HSD17B7. This mechanic's only job is to make sure there is enough cholesterol oil in the hair cells of your ear. If this mechanic goes on strike, the ear stops working, and you go deaf.

---

The Story of the Discovery

1. Finding the Mechanic

The scientists looked at tiny fish (zebrafish) and mice. They found that the HSD17B7 protein is everywhere in the hearing cells, but it's practically absent in other parts of the body. It's like finding a specialized mechanic who only works in the engine room of a submarine and nowhere else.

2. What Happens When the Mechanic is Missing?

The scientists created fish and mice without this HSD17B7 mechanic.

• The Result: The hair cells ran out of cholesterol "oil."
• The Consequence: The hair cells became stiff and sluggish. They couldn't vibrate properly when sound hit them.
• The Proof: When they made a loud noise, the mutant fish didn't jump (a natural "startle" response). They were essentially deaf. When they tried to fix the fish by injecting the missing mechanic's instructions (mRNA), the fish could hear again.

3. The Human Connection: A Broken Blueprint

The researchers then looked at a human family. They found a child with severe hearing loss who had a broken instruction manual (a genetic mutation) for the HSD17B7 mechanic.

• The Glitch: The mutation was a "nonsense" error. Imagine a recipe book where the instructions suddenly say "STOP" halfway through. The chef (the cell) tries to make the dish, but the result is a tiny, useless crumb instead of a full meal.
• The Impact: This broken protein didn't just fail to make cholesterol; it actually got in the way. It messed up where the cholesterol was stored inside the cell, like a spilled oil can making a mess on the floor instead of lubricating the engine.

4. The "RER1" Mystery

The scientists dug deeper to see why the broken protein caused so much trouble. They found that the healthy HSD17B7 protein usually has a "handshake" with another protein called RER1.

• The Analogy: Think of RER1 as a security guard at the factory door. Its job is to make sure the HSD17B7 mechanic stays in the right room (the Endoplasmic Reticulum) to do its job.
• The Breakup: The broken mutant protein (p.E182*) lost its ability to shake hands with the security guard. Because it couldn't hold the guard's hand, it wandered off into the wrong parts of the cell. Once it was lost, it couldn't make cholesterol, and it started causing chaos, disrupting the cell's internal organization.

Why This Matters

1. New Cause of Deafness: Before this, we didn't know that a specific enzyme making cholesterol inside the ear cell was a major cause of hearing loss. Now, HSD17B7 is a new suspect in the "Who's Who" of deafness genes.
2. The "Goldilocks" Zone: The study shows that hearing cells need the right amount of cholesterol. Too little, and they freeze up. But interestingly, having too much cholesterol didn't break the cells in their experiments. They just needed a minimum threshold to function.
3. Future Hope: By understanding that this specific protein is the key to keeping ear cells lubricated, doctors might one day develop treatments (like gene therapy or drugs) to fix the cholesterol supply in people with hearing loss.

In a Nutshell

Your ears need oil (cholesterol) to hear. A specific protein (HSD17B7) is the factory worker that makes that oil. If that worker is missing or broken, the factory shuts down, the oil runs out, and the ear goes silent. This paper found the broken worker in a human patient and proved exactly how the machine broke down.

Technical Summary

1. Problem Statement

Hearing loss is a major global health burden, with genetic factors accounting for approximately 60% of congenital cases. While over 150 non-syndromic deafness genes have been identified, the molecular mechanisms underlying sensory hair cell (HC) dysfunction remain incompletely understood. Cholesterol is critical for maintaining the structural integrity and biophysical properties of hair cell membranes, particularly the stereocilia where mechanotransduction (MET) occurs. Although dysregulated cholesterol homeostasis is linked to various forms of hearing loss, the specific contribution of hair cell-intrinsic cholesterol biosynthesis to auditory physiology and the identity of the enzymes responsible remain poorly defined. This study aims to investigate the role of HSD17B7 (17β-Hydroxysteroid dehydrogenase type 7), a key enzyme in the post-lanosterol cholesterol biosynthetic pathway, in sensory hair cell function and its potential association with human hearing loss.

2. Methodology

The study employed a multi-disciplinary approach combining genetics, molecular biology, biochemistry, and behavioral assays across zebrafish, mouse, and human models:

• Expression Profiling:
  • Analyzed public and in-house single-cell RNA sequencing (scRNA-seq) datasets from zebrafish and mouse inner ears to map hsd17b7 expression.
  • Validated expression using Whole-mount in situ hybridization (WISH), immunostaining, and confocal microscopy in zebrafish and mouse tissues.
• Genetic Manipulation in Zebrafish:
  • Generated hsd17b7 knockout (KO) mutants using CRISPR/Cas9.
  • Created morpholino (Mo) knockdown models to target exon 1/intron 1 splicing.
  • Performed rescue experiments by microinjecting wild-type (WT) and mutant human HSD17B7 mRNA into mutant embryos.
• Functional Assays:
  • Acoustic Startle Response: Measured swimming trajectories, velocity, and distance in response to sound stimuli in zebrafish larvae.
  • Mechanotransduction (MET) Activity: Used FM4-64 vital dye uptake assays to assess functional MET channel activity in hair cells.
  • Cholesterol Quantification: Measured total cellular cholesterol in HEI-OC1 cells (mouse auditory cell line) and visualized cholesterol distribution using the D4H-mCherry probe (a cholesterol-binding sensor) in both cell culture and live zebrafish.
• Human Genetic Analysis:
  • Conducted Whole-Genome Sequencing (WGS) on a proband with bilateral profound congenital hearing loss.
  • Identified and validated a heterozygous nonsense variant (c.544G>T; p.E182**) in HSD17B7.
• Molecular Mechanism Investigation:
  • Subcellular Localization: Immunofluorescence co-staining with ER markers (Calnexin) and ER retention receptor (RER1).
  • Protein Interactions: Co-immunoprecipitation (Co-IP) followed by LC-MS/MS proteomics to identify interacting partners of WT vs. mutant HSD17B7.
  • Stability Assays: RT-qPCR and mRNA stability assays (Actinomycin D treatment) to assess transcript half-life.
  • Transcriptomics: scRNA-seq on FACS-sorted hair cells from WT and hsd17b7 mutants to analyze transcriptional remodeling.

3. Key Contributions

• Discovery of HSD17B7 as a Hair Cell Regulator: Established that HSD17B7 is highly enriched in sensory hair cells (both lateral line and inner ear) across vertebrates and is essential for maintaining intracellular cholesterol levels.
• Identification of a Novel Deafness Gene: Identified a heterozygous nonsense variant (p.E182**) in HSD17B7 in a patient with profound hearing loss, linking this gene to human sensorineural hearing loss.
• Mechanistic Insight into Mutation Pathogenicity: Demonstrated that the p.E182** mutation causes hearing loss through a dual mechanism:
  1. Haploinsufficiency: Reduced mRNA stability and protein abundance.
  2. Dominant-Negative/Toxic Effect: Disruption of the interaction with the ER retention receptor RER1, leading to aberrant subcellular localization, cholesterol misdistribution, and impaired MET function.
• Cholesterol-MET Link: Provided direct evidence that hair cell-intrinsic cholesterol synthesis is a prerequisite for functional mechanotransduction and acoustic startle responses.

4. Key Results

• Expression: hsd17b7 is specifically enriched in sensory hair cells (LLHCs, CHCs, OHCs, IHCs) and increases during hair cell maturation.
• Loss-of-Function Phenotypes:
  • hsd17b7 mutants and morphants exhibited significantly reduced acoustic startle responses and decreased FM4-64 uptake (indicating MET dysfunction).
  • Mutants showed a ~16% reduction in hair cell number and a ~40% reduction in MET activity.
  • Cholesterol levels (measured by D4H-mCherry intensity) were significantly reduced in mutant hair cells.
• Transcriptional Remodeling: scRNA-seq revealed that hsd17b7 deficiency leads to the downregulation of cholesterol biosynthesis pathways and selective remodeling of MET-associated gene modules.
• Human Variant Characterization:
  • The p.E182** variant introduces a premature stop codon, truncating the protein and removing the transmembrane and cytoplasmic domains.
  • The mutant mRNA failed to rescue MET defects or behavioral deficits in zebrafish hsd17b7 mutants.
  • Overexpression of the mutant protein in wild-type zebrafish impaired startle responses and MET, suggesting a toxic gain-of-function or dominant-negative effect.
• Molecular Mechanism:
  • Localization: WT HSD17B7 localizes to the Endoplasmic Reticulum (ER) and co-localizes with RER1. The p.E182** mutant fails to localize to the ER, forming cytoplasmic aggregates.
  • Interaction: Co-IP and GST pull-down assays confirmed that WT HSD17B7 binds RER1, while the mutant does not. This loss of RER1 interaction explains the mislocalization.
  • Stability: The p.E182** mutation significantly reduces mRNA stability and protein levels.
  • Cholesterol Distribution: Expression of the mutant protein in HEI-OC1 cells and zebrafish hair cells caused aberrant aggregation of cholesterol (D4H signal), disrupting normal distribution.

5. Significance

This study fundamentally advances the understanding of the molecular basis of hearing loss by:

1. Linking Lipid Metabolism to Hearing: It establishes that the de novo synthesis of cholesterol within hair cells is not merely supportive but essential for the biophysical function of the mechanotransduction machinery.
2. Defining a New Genetic Etiology: It identifies HSD17B7 as a candidate gene for non-syndromic sensorineural hearing loss, expanding the genetic landscape of deafness.
3. Elucidating Pathogenic Mechanisms: It provides a clear mechanistic model where a nonsense mutation leads to both loss of function (via reduced expression) and gain of toxic function (via mislocalization and cholesterol disruption), explaining the severity of the phenotype in a heterozygous patient.
4. Therapeutic Implications: The findings suggest that maintaining cholesterol homeostasis in hair cells is a potential therapeutic target. Furthermore, understanding the RER1-HSD17B7 interaction could inform strategies to correct protein mislocalization in related genetic disorders.

In conclusion, the paper demonstrates that HSD17B7 is a conserved, essential regulator of hair cell function via cholesterol biosynthesis, and its dysfunction, specifically through the p.E182** variant, is a direct cause of profound hearing loss.